Navigation Links
Breast Cancer Message Barred in Eli Lilly's Hometown
Date:11/3/2010

SAN FRANCISCO, Nov. 3, 2010 /PRNewswire-USNewswire/ --Breast Cancer Action (BCA) learned today that its efforts to deliver a message to Eli Lilly & Company via a billboard in Indianapolis have been blocked.  The message:  "Eli Lilly is making us sick.  Tell them to stop" was rejected by every billboard company in Indianapolis, Lilly's hometown.

Despite working within the guidelines of each billboard company contacted, the advocacy group has been turned down because of the content of the message.  At a time when political advertizing across the nation has reached an all time high, the rejection of BCA's message raises critical questions about who controls the media when it comes to public health.

"We are talking about women's health here.  A breast cancer organization's message about the impact of a drug company's behavior is being kept off billboards in the company's home town.  When corporate influence runs this deep, the public should be outraged. We certainly are," said BCA executive director Barbara Brenner.

The public's health is at stake.  Eli Lilly is the sole worldwide manufacturer of rBGH (recombinant bovine growth hormone also known as rBST) which is sold under the name Posilac and has long been linked to cancer.  The artificial hormone is given to dairy cows to stimulate milk production.

Breast Cancer Action's "Milking Cancer" campaign demands Eli Lilly stop manufacturing the artificial stimulant rBGH.  In September 2010, signatures were gathered from over 6,732 individuals—one for each day that rBGH has been on the market—committed to delivering a message to Eli Lilly via a billboard in Indianapolis. For more information see www.milkingcancer.org.

Breast Cancer Action is a non-profit education and advocacy organization that does not accept funding from pharmaceutical companies or any other organizations that profit from or contribute to the breast cancer epidemic.


'/>"/>
SOURCE Breast Cancer Action
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CyberKnife Radiosurgery for Early-Stage Breast Cancer
2. 10 Tips for Breast Cancer Survivors
3. Celtic Pharma Announces Issuance of U.S. Patent 7,816,323 for Xerecept® in Combination with Avastin® as a Treatment for Breast and Colon Cancers
4. 10 Tips for Breast Cancer Screening and Early Detection
5. Jefferson Radiology Becomes First Diagnostic Imaging Group in Connecticut to Add Automated Ultrasound Capability for Screening Women with Dense Breast Tissue
6. Alma Lasers Joins the Fight Against Breast Cancer with the Launch of the NEW SopranoXLi
7. SightLine Health Adds Naviscan PEM Technology to Breast Cancer Treatment Services
8. FUJIFILM Revitalizes Images of Health Breast Cancer Awareness Initiative
9. FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
10. The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer
11. Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... -- Revolutionary technology includes multi-speaker listening to ... leaders in advanced audiology and hearing aid technology, has ... the world,s first internet connected hearing aid that opens ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... firsts,: , TwinLink™ - the first dual ...
Breaking Medicine Technology:
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):